Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study to Evaluate Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Simponi® (Golimumab)

NCT03557853 is registered in ClinicalTrials.gov with MSD Pharmaceuticals LLC as lead sponsor.

NCT NCT03557853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03557853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study to Evaluate Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Simponi® (Golimumab)
Lead sponsor
MSD Pharmaceuticals LLC
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
June 30, 2021
Enrollment
39 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, coxitis